J. Stocks

2.8k total citations
75 papers, 2.3k citations indexed

About

J. Stocks is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J. Stocks has authored 75 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Surgery and 27 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J. Stocks's work include Diabetes, Cardiovascular Risks, and Lipoproteins (28 papers), Lipid metabolism and disorders (26 papers) and Lipoproteins and Cardiovascular Health (21 papers). J. Stocks is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (28 papers), Lipid metabolism and disorders (26 papers) and Lipoproteins and Cardiovascular Health (21 papers). J. Stocks collaborates with scholars based in United Kingdom, United States and Japan. J. Stocks's co-authors include D. J. Galton, A. Rees, John M.C. Gutteridge, James A. Thorn, David Galton, Francisco E. Baralle, Carol C. Shoulders, G. Holdsworth, D. J. Galton and M. F. Murphy and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nucleic Acids Research.

In The Last Decade

J. Stocks

74 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Stocks United Kingdom 23 1.0k 853 719 525 353 75 2.3k
Christian Landou Sweden 14 650 0.6× 735 0.9× 950 1.3× 228 0.4× 88 0.2× 25 2.7k
Peter Båvenholm Sweden 21 947 0.9× 635 0.7× 467 0.6× 877 1.7× 111 0.3× 27 2.7k
Junji Koizumi Japan 27 1.4k 1.4× 2.5k 2.9× 684 1.0× 903 1.7× 188 0.5× 83 3.7k
Jeffrey M. Hoeg United States 28 735 0.7× 1.4k 1.7× 696 1.0× 647 1.2× 232 0.7× 68 3.0k
John W. Gaubatz United States 27 710 0.7× 1.5k 1.8× 450 0.6× 529 1.0× 94 0.3× 42 2.7k
Eak Kyun Shin South Korea 31 1.1k 1.1× 1.3k 1.5× 1.3k 1.8× 332 0.6× 280 0.8× 123 3.2k
A M Scanu United States 15 533 0.5× 1.3k 1.5× 424 0.6× 349 0.7× 75 0.2× 24 1.9k
P Avogaro Italy 22 1.2k 1.2× 1.5k 1.7× 525 0.7× 428 0.8× 111 0.3× 69 2.8k
Hideki Hidaka Japan 26 730 0.7× 1.5k 1.8× 257 0.4× 1.1k 2.0× 218 0.6× 108 3.1k
J C Fruchart France 28 1.3k 1.3× 1.4k 1.6× 491 0.7× 849 1.6× 121 0.3× 87 2.7k

Countries citing papers authored by J. Stocks

Since Specialization
Citations

This map shows the geographic impact of J. Stocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Stocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Stocks more than expected).

Fields of papers citing papers by J. Stocks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Stocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Stocks. The network helps show where J. Stocks may publish in the future.

Co-authorship network of co-authors of J. Stocks

This figure shows the co-authorship network connecting the top 25 collaborators of J. Stocks. A scholar is included among the top collaborators of J. Stocks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Stocks. J. Stocks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Needham, Edward W., Raj K. Mattu, Alan Rees, J. Stocks, & D. J. Galton. (1994). A Polymorphism in the Human Apolipoprotein AI Promoter Region: A Study in Hypertriglyceridaemic Patients. Human Heredity. 44(2). 94–99. 12 indexed citations
2.
Baroni, Marco Giorgio, et al.. (1992). Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM). Human Genetics. 88(5). 557–561. 37 indexed citations
3.
Bouloux, Pierre‐Marc, et al.. (1991). Insulin receptor gene polymorphisms in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 34(4). 260–264. 8 indexed citations
4.
Rinder, Henry M., et al.. (1991). Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion. 31(5). 409–414. 239 indexed citations
5.
Thorn, James A., John Chamberlain, John Alcolado, et al.. (1990). Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis. 85(1). 55–60. 83 indexed citations
6.
Chamberlain, John, James A. Thorn, Ruth Morgan, et al.. (1990). Genetic Variation at the Lipoprotein Lipase Gene Associates with Coronary Arteriosclerosis. Advances in experimental medicine and biology. 285. 275–279. 8 indexed citations
7.
Oka, Kazuhiro, George T. Tkalcevic, J. Stocks, D. J. Galton, & W. Virgil Brown. (1989). Nucleotide sequence of PvuII polymorphic site at the human lipoprotein llpase gene locus. Nucleic Acids Research. 17(16). 6752–6752. 20 indexed citations
8.
Chamberlain, John, James A. Thorn, Koichiro Oka, D. J. Galton, & J. Stocks. (1989). DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis. 79(1). 85–91. 113 indexed citations
9.
Baroni, Marco Giorgio, et al.. (1989). Stu I RFLP at the human Hep G2/Erythrocyte glucose transporter (GLUT) gene locus. Nucleic Acids Research. 17(8). 3330–3330. 2 indexed citations
10.
Li, Shurui, et al.. (1988). Bst-1 RFLP at the human lipoprotein lipase (LPL) gene locus. Nucleic Acids Research. 16(24). 11856–11856. 12 indexed citations
11.
Li, Shurui, et al.. (1988). Pvu-II RFLP at the human lipoprotein lipase (LPL) gene locus. Nucleic Acids Research. 16(5). 2358–2358. 21 indexed citations
12.
Stocks, J., et al.. (1988). DNA Polymorphisms of the Insulin Receptor Gene in Japanese Subjects with Non-Insulin-Dependent Diabetes mellitus. Human Heredity. 38(5). 273–276. 8 indexed citations
13.
Knisely, A. S., Patricia O’Shea, J. Stocks, & James E. Dimmick. (1988). Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: An approach to biopsy diagnosis. The Journal of Pediatrics. 113(5). 871–874. 51 indexed citations
14.
Thomas, D J B, et al.. (1987). HDL subfractions and angiographically defined coronary artery disease. International Journal of Clinical Practice. 41(5). 741–742. 1 indexed citations
15.
Kessling, Anna M., N I Jowett, A. Rees, et al.. (1985). DNA polymorphisms flanking the apo A-1 and insulin genes and type III hyperlipidaemia. Human Genetics. 69(3). 275–276. 21 indexed citations
16.
Rees, Aled, et al.. (1984). Raised intracranial pressure due to large intracranial xanthoma.. BMJ. 288(6432). 1722–1723. 12 indexed citations
17.
Jowett, N I, A. Rees, Larry G. Williams, et al.. (1984). Insulin and apolipoprotein A-1/C-III gene polymorphisms relating to hypertriglyceridaemia and diabetes mellitus. Diabetologia. 27(2). 180–183. 22 indexed citations
18.
Barrowcliffe, T W, J. Stocks, & Elaine Gray. (1982). Preparation of a Stable Phospholipid Reagent for Coagulation Assays. Pathophysiology of Haemostasis and Thrombosis. 11(2). 96–101. 12 indexed citations
19.
Gutteridge, John M.C. & J. Stocks. (1981). Caeruloplasmin: Physiological and Pathological Perspectives. CRC Critical Reviews in Clinical Laboratory Sciences. 14(4). 257–329. 194 indexed citations
20.
Stocks, J., G. Holdsworth, & David Galton. (1979). HYPERTRIGLYCERIDÆMIA ASSOCIATED WITH AN ABNORMAL TRIGLYCERIDE-RICH LIPOPROTEIN CARRYING EXCESS APOLIPOPROTEIN C-III-2. The Lancet. 314(8144). 667–671. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026